Literature DB >> 19619782

Relief of branch pulmonary artery stenosis reduces pulmonary valve insufficiency in a swine model.

Christopher J Petit1, Matthew J Gillespie, Matthew A Harris, Travis L Seymour, Timothy Y Liu, Azeem Khan, J William Gaynor, Jonathan J Rome.   

Abstract

OBJECTIVE: We sought to determine the impact of relieving branch pulmonary artery stenosis on pulmonary valve insufficiency and right ventricular function. Long-standing pulmonary insufficiency causes progressive right ventricular dilatation, leading to decreased right ventricular function. Adults with pulmonary insufficiency are at risk of decreased exercise tolerance, arrhythmias, and sudden cardiac death. Branch pulmonary artery stenosis frequently occurs in these patients, and the presence of branch stenosis may exacerbate valve insufficiency.
METHODS: Neonatal piglets (n = 7) underwent surgery to create pulmonary insufficiency and left pulmonary artery stenosis. At 3 months of age, the animals underwent baseline cardiac magnetic resonance imaging followed by stenting of the left pulmonary artery. A repeat magnetic resonance imaging scan was performed 1 week after intervention. Magnetic resonance imaging evaluation included (1) velocity mapping to assess the forward and reverse flow at the main, left and right pulmonary arteries, and aorta; and (2) volumetric assessment of the right ventricle.
RESULTS: Left pulmonary artery flow increased from 14.5% to 36.3% of total net flow after stenting (P < .01). Pulmonary regurgitation decreased from 38.7% to 27.4% (P < .02). Right ventricular ejection fraction improved from a median of 53.5% to 58.2% after stenting (P < .01). Cardiac index improved from a median of 2.7 to 3.5 L/min/m(2) (P = .01).
CONCLUSION: Relief of branch pulmonary artery stenosis reduces insufficiency and improves right ventricular systolic function in this animal model. This supports the practice of aggressive intervention in patients with branch pulmonary artery stenosis and pulmonary insufficiency.

Entities:  

Mesh:

Year:  2009        PMID: 19619782     DOI: 10.1016/j.jtcvs.2009.02.030

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Obstruction-induced pulmonary vascular remodeling.

Authors:  Ming-Jay Chow; Yu Zou; Huamei He; Francis X McGowan; David Zurakowski; Yanhang Zhang
Journal:  J Biomech Eng       Date:  2011-11       Impact factor: 2.097

2.  An ovine model of pulmonary insufficiency and right ventricular outflow tract dilatation.

Authors:  J Daniel Robb; Matthew A Harris; Masahito Minakawa; Evelio Rodriguez; Kevin J Koomalsingh; Takashi Shuto; Yoav Dori; Robert C Gorman; Joseph H Gorman; Matthew J Gillespie
Journal:  J Heart Valve Dis       Date:  2012-03

3.  Effectiveness and safety of percutaneous transcatheter implantation of pulmonary arterial stent in congenital heart disease.

Authors:  Hong Ki Ko; Young-Hwue Kim; Jeong Jin Yu; Jae-Kon Ko; In-Sook Park; Dong-Man Seo; Tae-Jin Yun; Jeong-Jun Park; Wan Sook Jang
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

4.  Non-invasive MRI Derived Hemodynamic Simulation to Predict Successful vs. Unsuccessful Catheter Interventions for Branch Pulmonary Artery Stenosis: Proof-of-Concept and Experimental Validation in Swine.

Authors:  Ryan Pewowaruk; John Ralphe; Luke Lamers; Alejandro Roldán-Alzate
Journal:  Cardiovasc Eng Technol       Date:  2021-05-18       Impact factor: 2.305

5.  Homograft durability after correction of pulmonary atresia and ventricular septal defect with or without systemic pulmonary collateral arteries.

Authors:  Pieter C van de Woestijne; Jamie L R Romeo; Ingrid van Beynum; Maarten Witsenburg; M Mostafa Mokhles; Ad J J C Bogers
Journal:  JTCVS Open       Date:  2021-09-24

6.  Stent interventions for pulmonary artery stenosis improve bi-ventricular flow efficiency in a swine model.

Authors:  Ryan J Pewowaruk; Gregory P Barton; Cody Johnson; J Carter Ralphe; Christopher J Francois; Luke Lamers; Alejandro Roldán-Alzate
Journal:  J Cardiovasc Magn Reson       Date:  2021-02-25       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.